CGON

CG Oncology, Inc. Common stock

Insider Trades

ActorHolding ValueLast TransactionAmountTransaction PriceCurrent Price
Graf Susan EDirector
--9.4k shares
Grant / ExerciseJun 4, 2026
$524.7K9.4k shares
$56.09
$60.80
Post Leonard EDirector
--9.4k shares
Grant / ExerciseJun 4, 2026
$524.7K9.4k shares
$56.09
$60.80
Rossi ChristinaDirector
--9.4k shares
Grant / ExerciseJun 4, 2026
$524.7K9.4k shares
$56.09
$60.80
Mulay JamesDirector
--9.4k shares
Grant / ExerciseJun 4, 2026
$524.7K9.4k shares
$56.09
$60.80
Tong Victor Edward JrDirector
--9.4k shares
Grant / ExerciseJun 4, 2026
$524.7K9.4k shares
$56.09
$60.80
Liu Brian Guan-ChyunDirector
--9.4k shares
Grant / ExerciseJun 4, 2026
$524.7K9.4k shares
$56.09
$60.80

News

seekingalpha.comCG Oncology, Inc. (CGON) Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026 Transcriptseekingalpha.comJun 9marketbeat.comCG Oncology Touts Cretostimogene Data, BLA Progress in Bladder Cancer Pushmarketbeat.comJun 7globenewswire.comCG Oncology to Present at Upcoming Investor Conferences in Juneglobenewswire.comMay 28marketbeat.comCG Oncology Touts Bladder Cancer Data, Q4 Filing Plans at RBC Conferencemarketbeat.comMay 20globenewswire.comSUO-CTC and CG Oncology Announce Award Recipients of the Second Annual Non-Muscle Invasive Bladder Cancer (NMIBC) Research Fellowship Awardglobenewswire.comMay 19